These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1647317)

  • 1. Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptor.
    Mattia A; Vanderah T; Mosberg HI; Omnaas JR; Bowen WD; Porreca F
    Eur J Pharmacol; 1991 Jan; 192(3):371-5. PubMed ID: 1647317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
    J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivo.
    Rothman RB; Bykov V; Jacobson AE; Rice KC; Long JE; Bowen WD
    Peptides; 1992; 13(4):691-4. PubMed ID: 1331996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5,Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange.
    Bowen WD; Hellewell SB; Kelemen M; Huey R; Stewart D
    J Biol Chem; 1987 Oct; 262(28):13434-9. PubMed ID: 2820969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
    Porreca F; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI
    J Pharmacol Exp Ther; 1992 Oct; 263(1):147-52. PubMed ID: 1328602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
    Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
    Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
    Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors.
    Calcagnetti DJ; Fanselow MS; Helmstetter FJ; Bowen WD
    Peptides; 1989; 10(2):319-26. PubMed ID: 2547203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE.
    Calcagnetti DJ; Bowen WD; Holtzman SG
    Brain Res; 1990 Feb; 509(2):205-12. PubMed ID: 2157520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole.
    Stamidis H; Young GA
    Peptides; 1993; 14(3):511-7. PubMed ID: 8392719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
    Qi JN; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.